Influence of route of administration on antileukemic activity of cyclocytidine.
D000284:Administration, Oral; D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D003500:Cyclization; D003562:Cytidine / Q000008:administration & dosage* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D007274:Injections, Intraperitoneal; D007939:Leukemia L1210 / Q000188:drug therapy; D051379:Mice
D000970:Antineoplastic Agents; D003562:Cytidine